Janus Henderson Group’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
GIM
PAI
GCM
Janus Henderson Group's BLUE Position: Q4 2023 in Review
Janus Henderson Group sold out of bluebird bio (BLUE) in Q4 2023, closing a stake of 2,030 shares — an estimated $123K sold.
Janus Henderson Group first reported a position in BLUE in Q2 2015 and held it in 11 quarters. The position peaked at $5.25M in Q2 2017. 187 funds tracked by Wall St. Rank hold BLUE as of Q4 2023.
- Janus Henderson Group reported no remaining bluebird bio position as of Q4 2023 after selling out during the quarter.
- Janus Henderson Group sold 2,030 bluebird bio shares in Q4 2023, an estimated $123K.
- Janus Henderson Group first reported a position in bluebird bio in Q2 2015 and held it in 11 quarters.
- Janus Henderson Group's bluebird bio position peaked at $5.25M in Q2 2017.
- 187 funds tracked by Wall St. Rank held bluebird bio as of Q4 2023.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.